My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Welcome

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Anixa Biosciences (ANIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNTech SE (BNTXResearch Report) and Anixa Biosciences (ANIXResearch Report).

BioNTech SE (BNTX)

H.C. Wainwright analyst Robert Burns reiterated a Hold rating on BioNTech SE today and set a price target of $330.00. The company’s shares closed last Monday at $345.00.

According to TipRanks.com, Burns is a 3-star analyst with an average return of 3.8% and a 37.1% success rate. Burns covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Black Diamond Therapeutics.

Currently, the analyst consensus on BioNTech SE is a Moderate Buy with an average price target of $318.40, which is a -9.3% downside from current levels. In a report issued on August 27, UBS also maintained a Hold rating on the stock with a $300.00 price target.

See today’s analyst top recommended stocks >>

Anixa Biosciences (ANIX)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences, with a price target of $11.00. The company’s shares closed last Monday at $5.48.

According to TipRanks.com, Chen is a top 100 analyst with an average return of 53.9% and a 56.0% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Anixa Biosciences with a $11.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BNTX: